Isthmus Partners’s Bausch Health BHC Stock Holding History

Isthmus Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-67	Closed	-$15K	–	275
2015 Q2	$15K	Buy	+67	New	+$14.9K	0.01%	233

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Isthmus Partners's BHC Position: Q3 2015 in Review

Isthmus Partners sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 67 shares — an estimated $15K sold.

Isthmus Partners first reported a position in BHC in Q2 2015 and held it in 1 quarter. The position peaked at $15K in Q2 2015. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

Isthmus Partners reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
Isthmus Partners sold 67 Bausch Health shares in Q3 2015, an estimated $15K.
Isthmus Partners first reported a position in Bausch Health in Q2 2015 and held it in 1 quarter.
Isthmus Partners's Bausch Health position peaked at $15K in Q2 2015.
546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Isthmus Partners's 13F filing for Q3 2015, filed 27 Oct 2015.